PERSPECTA

News from every angle

← Back to headlines

Definium Therapeutics Targets Three Phase III Readouts in 2026

Definium Therapeutics plans for three pivotal Phase III readouts in 2026, with enrollment progressing and its cash runway extended into 2028.

27 Feb, 02:58 — 27 Feb, 02:58
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha5h ago

Definium Therapeutics targets three pivotal Phase III readouts in 2026 as enrollment advances and cash runway extends into 2028

Read full article →

Related Stories

Philippine LTFRB Suspends Three TNCs Over Franchise Violations

just now

Merodi debut in Hong Kong shows Pop Mart’s struggle beyond IP darling Labubu

7m ago

Protests Block Mangalia Shipyard as Workers Demand Unpaid Wages

9m ago

Zenica Ironworks Faces Closure Amid Steel Imports and Coke Shortage

10m ago